바로가기메뉴

본문 바로가기 주메뉴 바로가기

The Complementary Role of FEV6 in Bronchodilator Reversibility Test for the Old Age

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.61 no.3, pp.227-232






  • Downloaded
  • Viewed

Abstract

Background: In the measurement of bronchodilator reversibility, the forced expiratory volume in one second(FEV1) and the forced vital capacity(FVC) are commonly used parameters and recommended criteria for the reversibility requiring an increase of more than 200ml and 12% above the baseline, respectively. However, aged patients do not often meet the criteria of an increase in volume(>200ml) even though the medical history of that patient is adequate for asthma. This study investigated the role of the forced expiratory volume in six seconds(FEV6) in the bronchodilator reversibility test in elderly patients. Methods: A total of 236 patients more than 65 years of age with a FEV1/FVC ratio<80% were enrolled in this study. The bronchodilator revesibility tests were examined. With the setting FEV1 as the baseline, the patients were divided into three groups; Group I : FEV1≧80% of the predicted value, Group II : 60%<FEV1<80% of the predicted value, Group III : FEV1≦60% of the predicted value. Results: Positive reversibility in the FEV1, FEV6, and FVC was in 33(14.0%), 49(20.8%) and 55(23.3%). However, Group III presented with reversibility in the FEV1, FEV6, and FVC in 15(22.4%), 30(44.8%) and 32(47.8%) respectively. Conclusions: The FEV6 might be used as a complementary parameter in bronchodilatror reversibility in elderly patients. However, more study will be needed to determine the usefulness of FEV6 in bronchodilator reversibility test. (Tuberc Respir Dis 2006; 61: 227-232)

keywords
FEV6, 폐기능검사, 노인, 진단, FEV6, Bronchodilator reversibility test, The old age., FEV6, Bronchodilator reversibility test, The old age.

Reference

1.

Killian KJ, (1993) Factors contributing to dyspnoea during bronchoconstriction and exercise in asthmatic subjects,

2.

Miller MR, (2005) Standardisation of spirometry,

3.

Pellegrino R, (2005) Interpretative strategies for lung function tests,

4.

Stoller JK, (1997) Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency:alpha1-Antitrypsin Deficiency Registry Study Group,

5.

Eaton T, (1999) Spirometry in primary care practice:the importance of quality assurance and the impact of spirometry workshops,

6.

Swanney MP, (2004) Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity,

7.

Akpinar-Elci M, (2006) FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace,

8.

American Thoracic Society, (1995) Standardization of Spirometry,1994 update,

9.

Pellegrino R, (1998) Assessing the reversibility of airway obstruction,

10.

Lorber DB, (1978) Responses to isoproterenol in a general population sample,

11.

Dales RE, (1988) Clinical interpretation of airway response to a bronchodilator:epidemiologic considerations,

12.

Anthonisen NR, (1986) Bronchodilator response in chronic obstructive pulmonary disease,

13.

Sourk RL, (1983) Bronchodilator testing:confidence intervals derived from placebo inhalations,

14.

Enright RL, (2002) The FEV1/FEV6 predicts lung function decline in adult smokers,

15.

Vandevoorde J, (2006) Obstructive and restrictive spirometric patterns:fixed cut-offs for FEV1/FEV6 and FEV6,

16.

Demir T, (2005) The role of FEV6 in the detection of airway obstruction,

17.

Killian KJ, (2000) Symptom perception during acute bronchoconstriction,

18.

Kendrick AH, (1993) Accuracy of perception of severity of asthma:patients treated in general practice,

19.

Nowak RM, (1982) Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma,

20.

Dow L, (1998) Asthma in older people,

Tuberculosis & Respiratory Diseases